Related Experiment Videos
Antidepressant treatment and neural plasticity
R S El-Mallakh1, C Peters, C Waltrip
1Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Kentucky 40292, USA. rselma01@athena.louisville.edu
Journal of Child and Adolescent Psychopharmacology
|February 24, 2001
Summary
Psychopharmacologic agents in children require caution due to potential impacts on developing brains. Further research, including animal studies, is needed to understand long-term effects on neurodevelopment.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pharmacology
Background:
- Prescribing psychopharmacologic agents in children presents unique challenges.
- Neurobiologic considerations, particularly the impact on ongoing brain development, are crucial.
Purpose of the Study:
- To explore the theoretical implications of psychopharmacologic agent use in developing nervous systems.
- To highlight the need for prudence in pediatric psychopharmacology.
Main Methods:
- Review of ancillary data regarding neurobiologic effects.
- Consideration of animal studies on long-term antidepressant administration in immature subjects.
Main Results:
- Available data are insufficient to directly address medication effects on child brain development.
- Theoretical concerns exist regarding agents altering serotonergic function and neuronal plasticity.
Conclusions:
- Prudence is advised when prescribing psychopharmacologic agents to children.
- Potential alterations in neuronal wiring during development warrant further investigation.
- Animal studies may provide insights into clinical concerns of long-term medication effects.